Literature DB >> 16945914

Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.

Niloofar Rasti1, Fatuma Namusoke, Arnaud Chêne, Qijun Chen, Trine Staalsoe, Mo-Quen Klinkert, Florence Mirembe, Fred Kironde, Mats Wahlgren.   

Abstract

The harmful effects of pregnancy-associated malaria (PAM) are engendered by the heavy sequestration of Plasmodium falciparum-parasitized RBCs in the placenta. It is well documented that this process is mediated by interactions of parasite-encoded variant surface antigens and placental receptors. A P. falciparum erythrocyte membrane protein 1 variant, VAR2CSA, and the placental receptor chondroitin sulfate A (CSA) are currently the focus of PAM research. A role for immunoglobulins (IgG and IgM) from normal human serum and hyaluronic acid as additional receptors in placental sequestration have also been suggested. We show here (i) that CSA and nonimmune IgG/IgM binding are linked phenotypes of in vitro-adapted parasites, (ii) that a VAR2CSA variant shown to bind CSA also harbors IgG- and IgM-binding domains (DBL2-X, DBL5-epsilon, and DBL6-epsilon), and (iii) that IgG and IgM binding and adhesion to multiple receptors (IgG/IgM/HA/CSA) rather than the exclusive binding to CSA is a characteristic of fresh Ugandan placental isolates. These findings are of importance for the understanding of the pathogenesis of placental malaria and have implications for the ongoing efforts to develop a global PAM vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945914      PMCID: PMC1564255          DOI: 10.1073/pnas.0601519103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta.

Authors:  Michal Fried; Gonzalo J Domingo; Channe D Gowda; Theonest K Mutabingwa; Patrick E Duffy
Journal:  Exp Parasitol       Date:  2006-01-23       Impact factor: 2.011

2.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites.

Authors:  Benoit Gamain; Adama R Trimnell; Christine Scheidig; Artur Scherf; Louis H Miller; Joseph D Smith
Journal:  J Infect Dis       Date:  2005-02-11       Impact factor: 5.226

3.  Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype.

Authors:  Michael F Duffy; Timothy J Byrne; Salenna R Elliott; Danny W Wilson; Stephen J Rogerson; James G Beeson; Rintis Noviyanti; Graham V Brown
Journal:  Mol Microbiol       Date:  2005-05       Impact factor: 3.501

4.  Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria.

Authors:  J G Beeson; S J Rogerson; B M Cooke; J C Reeder; W Chai; A M Lawson; M E Molyneux; G V Brown
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A.

Authors:  J Gysin; B Pouvelle; N Fievet; A Scherf; C Lépolard
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria.

Authors:  Adama R Trimnell; Susan M Kraemer; Sandeep Mukherjee; David J Phippard; Joel H Janes; Eric Flamoe; Xin-zhuan Su; Philip Awadalla; Joseph D Smith
Journal:  Mol Biochem Parasitol       Date:  2006-04-18       Impact factor: 1.759

7.  Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates.

Authors:  Nicaise G Tuikue Ndam; Nadine Fievet; Gwladys Bertin; Gilles Cottrell; Alioune Gaye; Philippe Deloron
Journal:  J Infect Dis       Date:  2004-10-27       Impact factor: 5.226

8.  Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies.

Authors:  Jean-Philippe Semblat; Ahmed Raza; Sue A Kyes; J Alexandra Rowe
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

9.  A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A.

Authors:  Nicola K Viebig; Benoit Gamain; Christine Scheidig; Catherine Lépolard; Jude Przyborski; Michael Lanzer; Jürg Gysin; Artur Scherf
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

10.  The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors.

Authors:  Q Chen; A Heddini; A Barragan; V Fernandez; S F Pearce; M Wahlgren
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  34 in total

1.  Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax.

Authors:  Sedami Gnidehou; Justin Doritchamou; Eliana M Arango; Ana Cabrera; Maria Isabel Arroyo; Kevin C Kain; Nicaise Tuikue Ndam; Amanda Maestre; Stephanie K Yanow
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.

Authors:  Lea Barfod; Michael B Dalgaard; Suzan T Pleman; Michael F Ofori; Richard J Pleass; Lars Hviid
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

3.  Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6ℇ-FCR3 of the Plasmodium falciparum VAR2CSA protein.

Authors:  Anneleen Vuchelen; Els Pardon; Jan Steyaert; Benoît Gamain; Remy Loris; Nico A J van Nuland; Stéphanie Ramboarina
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-02-22

4.  Placental malaria in Colombia: histopathologic findings in Plasmodium vivax and P. falciparum infections.

Authors:  Jaime Carmona-Fonseca; Eliana Arango; Amanda Maestre
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

Review 5.  Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.

Authors:  Mats Wahlgren; Suchi Goel; Reetesh R Akhouri
Journal:  Nat Rev Microbiol       Date:  2017-06-12       Impact factor: 60.633

6.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.

Authors:  Lea Barfod; Nadia L Bernasconi; Madeleine Dahlbäck; David Jarrossay; Pernille Haste Andersen; Ali Salanti; Michael F Ofori; Louise Turner; Mafalda Resende; Morten A Nielsen; Thor G Theander; Federica Sallusto; Antonio Lanzavecchia; Lars Hviid
Journal:  Mol Microbiol       Date:  2006-12-14       Impact factor: 3.501

7.  Effect of cytokine treatment on the in vitro expression of the P. falciparum adhesion receptor chondroitin-4-sulphate on the surface of human choriocarcinoma (BeWo) cells.

Authors:  Yvonne Adams; Reinhard Schwartz-Albiez; James S McCarthy; Katherine T Andrews
Journal:  Parasitol Res       Date:  2007-02-16       Impact factor: 2.289

8.  Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta.

Authors:  Bethann S Hromatka; Sadiki Ngeleza; Jennifer J Adibi; Richard K Niles; Antoinette K Tshefu; Susan J Fisher
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

9.  Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida.

Authors:  Claudio R F Marinho; Rita Neres; Sabrina Epiphanio; Lígia A Gonçalves; Manuela Beirão Catarino; Carlos Penha-Gonçalves
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

10.  Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.

Authors:  Kim J M Brolin; Kristina E M Persson; Mats Wahlgren; Stephen J Rogerson; Qijun Chen
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.